Early Stage Hodgkin’s Lymphoma

Post-Transplant Adcetris® Improves Treatment of Hodgkin’s Lymphoma and is Likely to Become New Standard of Care (12-12-2014)

The use of post stem cell transplant (SCT) maintenance therapy with Adcetris® (brentuximab vedotin) significantly improved progression-free survival in Hodgkin’s Lymphoma (HL) according to the results of a clinical trail presented at the 56th American... Continue Reading

Radiation Therapy Improves 10-Year Survival for Patients With Early Hodgkin’s Lymphoma (10-30-2014)

According to a large observational study based on the National Cancer Database (NCDB), adding consolidation radiation therapy to chemotherapy significantly improves 10-year survival in patients with stage I and II Hodgkin’s lymphoma (HL).  The findings... Continue Reading

Rituxan Active in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma (02-26-2014)

Rituxan® (rituximab) was active in previously treated and untreated patients with nodular lymphocyte–predominant Hodgkin lymphoma, according to the results of a phase II study published in the Journal of Clinical Oncology. Most patients relapsed,... Continue Reading

Children with Favorable-Risk Hodgkin’s Lymphoma May Benefit from Limited Radiation Therapy (07-6-2012)

Children with favorable-risk Hodgkin’s lymphoma who achieve a complete early response to chemotherapy may not require radiation therapy or may undergo limited radiation therapy, according to the results of a study published in the Journal of the American... Continue Reading

Lymphoma During Pregnancy Can Have Good Outcomes (03-14-2012)

Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good. This was true for women who began lymphoma treatment during the second or third trimester of pregnancy, as well as women who deferred treatment... Continue Reading

Chemotherapy Alone Effective for Hodgkin’s Lymphoma (02-10-2012)

Among patients with Stage IA or IIA nonbulky Hodgkin’s lymphoma, treatment with chemotherapy alone resulted in better overall survival than treatment that included radiation therapy. These results were published in the New England Journal of Medicine. Hodgkin’s... Continue Reading

Limited Therapy May Cure a Significant Fraction of Pediatric Patients with Early-Stage Hodgkin Lymphoma (06-13-2011)

At the 2011 meeting of the American Society of Clinical Oncology, researchers involved in the Pediatric Oncology Study Group (POG) reported that selected pediatric patients with stage I and II Hodgkin lymphoma could be cured without alkylating agent chemotherapy... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (05-23-2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients. For some patients, however, symptoms may persist... Continue Reading

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08-27-2010)

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published... Continue Reading

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08-27-2010)

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published... Continue Reading

Next Page »